Get started
Author

Helen Latimer

Real-World Cost of Care for Commercially Insured versus Medicare Patients with Metastatic Pancreatic Cancer Who Received Guideline-Recommended Therapies.
2021 · Samantha Tomicki, Gabriela Dieguez, et al. · PubMed Central · 6
Real-World Treatment Patterns Among Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Who Initiated an Asparaginase Treatment after the Approval of Recombinant Erwinia (Rylaze)
2023 · Luke Maese, Helen Latimer, et al. · Blood · 2
ABCL-241: Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting
2026 · Barbara Furtado, Helen Latimer, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-241: Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting
2026 · Barbara Furtado, Helen Latimer, et al. · Clinical Lymphoma Myeloma & Leukemia
Rwd6 Real-world Transition Probability Analyses Among Unresectable Locally Advanced (la) Esophageal/gastroesophageal Junction Cancer (ec/gejc) Patients Treated With Definitive Chemoradiotherapy (dcrt) at Community Oncology Centers
2026 · Liya Wang, Helen Latimer, et al. · Value in Health
Rwd54 Evolution of Homologous Recombination Repair (hrr) Genetic Testing by Race Among Patients With Metastatic Prostate Cancer (mpc) in a Large Community Oncology Setting in the Us, 2015-2024
2026 · Helen Latimer, Zhaohui Su, et al. · Value in Health
Real-world characteristics, treatment patterns, and outcomes of newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients treated in first-line (1L) in the United States (US) community oncology setting.
2026 · Barbara Furtado, Helen Latimer, et al. · Journal of Clinical Oncology
PDF
Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancer
2026 · Natalia Sadetsky, Patricia Prince, et al. · Scientific Reports
PDF
Real-world clinical characteristics and outcomes of patients with locally advanced, unresectable esophageal/gastroesophageal junction cancer treated with definitive chemoradiotherapy in the United States community oncology setting
2026 · Adriana Valderrama, Karthik Ramakrishnan, et al. · Frontiers in Oncology
PDF
Real-world characteristics and outcomes of patients with relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL) who received second line therapy, stratified by stem cell transplant status
2025 · Helmneh Sineshaw, Helen Latimer, et al. · Blood
PDF
HPR146 Real-World BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) Testing Trends by Race for Patients with Metastatic Prostate Cancer (mPC) from 2015 to 2024 in the Community Oncology Setting in the United States (US)
2025 · Helen Latimer, Lisa Herms, et al. · Value in Health
RWD35 Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncology Clinics
2025 · Adriana Valderrama, Lisa Herms, et al. · Value in Health
RWD17 Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)
2025 · Lisa Herms, Helen Latimer, et al. · Value in Health
Biomarkertesting in metastatic colorectal cancer (mCRC): 2015-2024 trends in the United States (US) community oncology setting.
2025 · Helen Latimer, Lisa Herms, et al. · Journal of Clinical Oncology
Increased Risk of Hypertension Onset Among Patients With Narcolepsy Newly Treated With High-Sodium Oxybate (P5-13.002)
2023 · Rami Ben-Joseph, Virend Somers, et al. · Neurology
Prevalence of CKD: Comparison of Real-World Data (RWD) Sources to the US National Health and Nutrition Examination Survey (NHANES)
2022 · Joseph Stavas, Emily L. Butler, et al. · Journal of the American Society of Nephrology
Dispersion in total cost of care for Medicare fee-for-service (FFS) patients with metastatic pancreatic cancer receiving FDA-approved/NCCN Category 1 regimens at teaching versus non-teaching institutions.
2021 · Helen Latimer, Samantha Tomicki, et al. · Journal of Clinical Oncology
Dispersion in total cost of care for Medicare fee-for-service (FFS) patients with metastatic pancreatic cancer receiving FDA-approved/NCCN Category 1 regimens at 340B verus non-340B institutions.
2021 · Helen Latimer, Samantha Tomicki, et al. · Journal of Clinical Oncology
Anti-cancer mechanism of the flavonoid icariin (ICA) and its derivative ICT on the tumor microenvironment (46.41)
2012 · Erika Eksioglu, Jun-Min Zhou, et al. · The Journal of Immunology
Works count: 19
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type